Sudhir Mehta Chairman Markand Bhatt S. H. Bhojani Dr. Prasanna
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Sudhir Mehta Chairman Markand Bhatt S. H. Bhojani Dr. Prasanna as PDF for free.
More details
- Words: 473
- Pages: 2
DIRECTORS Sudhir Mehta Chairman Markand Bhatt S. H. Bhojani Dr. Prasanna Chandra Kiran Karnik Sanjay Lalbhai Dr. C. Dutt Director (Research & Development) Samir Mehta Managing Director
Sl. No.
1.
Name of Director
Director Type/ Designation on the Board
Independent Director
Relationship, with another Director (Yes/No)
Age
Education
Occupation
First Date of Appointment as a Director
SUDHIR UTTAMLAL MEHTA (MR.) SAMIR UTTAMLAL MEHTA (MR.)
EXECUTIVE CHAIRMAN MANAGING DIRECTOR
NO
YES
55
B.SC.
NO
YES
46
B.COM./ M.B.A.
3.
MARKAND INDUPRASAD BHATT (MR.)
NONEXECUTIVE DIRECTOR
NO
NO
63
B.COM./ P.G.DIPLOMAMANAGEMENT,IIM AHMEDABAD
4.
SHASHIKANT HARILAL BHOJANI (MR.)
NONEXECUTIVE DIRECTOR
YES
NO
66
B.SC./ LL.M.
5.
CHAITANYA MAVINKURVE DUTT (DR.)
WHOLETIME DIRECTOR
NO
NO
58
M.D.-MEDICINE
6.
KIRAN SHARADCHANDRA KARNIK (MR.)
NONEXECUTIVE DIRECTOR
YES
NO
62
7.
SANJAY SHRENIK LALBHAI (MR.)
YES
NO
55
8.
PRASANNA CHANDRA SITAB CHANDRA SHRIMAL (DR.)
NONEXECUTIVE DIRECTOR NONEXECUTIVE DIRECTOR
B.SC.-PHYSICS/ 24/01/2001 P.G.DIPLOMAMANAGEMENT,IIM AHMEDABAD B.SC./ M.M.S. ENTREPRENEUR 23/01/2003
YES
NO
63
2.
Rs. in Crores
M.B.A./ PH.D.FINANCE
EXECUTIVE CHAIRMAN MANAGING DIRECTOR
23/06/1982
MANAGING DIRECTOR, TORRENT POWER GENERATION LTD. PARTNER, AMARCHAND & MANGALDAS & SURESH A.SHROFF & CO. WHOLETIME DIRECTORRESEARCH & DEVELOPMENT PRESIDENT, NASSCOM
19/10/2000
CONSULTANT & ACADEMICIAN
25/05/2001
20/08/1986
25/05/2001
27/06/2000
2007-08
2006-07
Sales & Operating Income
995.90
882.90
Operating Profits (PBDIT)
216.98
167.49
Less Depreciation
32.74
30.24
Less Net Interest Expense
18.40
13.15
165.84
124.10
Profit Before Tax & Exceptional Items Less Net Income Tax Expense Net Profit for the Period Balance brought forward from Last Year
10.32
11.14
155.52
112.96
62.02
48.39
217.53
161.35
Transfer to General Reserve
99.00
70.39
Proposed Equity Dividend
29.61
--
--
25.38
Distributable Profits Appropriated as under:
Interim Dividend Tax on Distributed Profits
5.03
3.56
Balance Carried Forward
83.89
62.02
Earnings Per Share
18.38
13.35
FINANCIAL RESULTS The summary of consolidated (Company and its subsidiaries) and standalone (Company) operating results for the year and appropriation of divisible profits is given below : (Rs. in Crores except per share data) Consolidated Standalone 2008-09 2007-08 2008-09 2007-08 Sales & Operating Income 1631 1355 1185 996 Operating Profits (PBDIT) 262 208 257 217 Less Depreciation 42 39 37 33 Less Net Interest Expense 19 20 20 18 Profit Before Exceptional Items & Tax 201 149 200 166 Less Exceptional Items 9 - - 9 - Less Tax Expense 7 14 4 10 Net Profit for the Year 185 135 187 156 Balance brought forward 3 2 84 62 Distributable Profits 188 137 271 218 Appropriated as under: Transfer to General Reserve 145 99 145 99 Proposed Equity Dividend 34 30 34 30 Tax on Distributed Profits 6 5 6 5 Balance Carried Forward 3 3 86 84 Earnings Per Share (Rs. per share) 21.79 15.92 22.07 18.38
Therapeutic Segment Company's Growth Segment Growth Cardiovascular 7.1% 13.2% Gastrointestinal 2.0% 8.2% CNS 9.5% 10.4% Anti-infective 4.2% 9.8% Pain management 1.2% 9.0% Anti-diabetics 20.1% 16.2% Source: ORG-IMS March 2009 MAT
Sl. No.
1.
Name of Director
Director Type/ Designation on the Board
Independent Director
Relationship, with another Director (Yes/No)
Age
Education
Occupation
First Date of Appointment as a Director
SUDHIR UTTAMLAL MEHTA (MR.) SAMIR UTTAMLAL MEHTA (MR.)
EXECUTIVE CHAIRMAN MANAGING DIRECTOR
NO
YES
55
B.SC.
NO
YES
46
B.COM./ M.B.A.
3.
MARKAND INDUPRASAD BHATT (MR.)
NONEXECUTIVE DIRECTOR
NO
NO
63
B.COM./ P.G.DIPLOMAMANAGEMENT,IIM AHMEDABAD
4.
SHASHIKANT HARILAL BHOJANI (MR.)
NONEXECUTIVE DIRECTOR
YES
NO
66
B.SC./ LL.M.
5.
CHAITANYA MAVINKURVE DUTT (DR.)
WHOLETIME DIRECTOR
NO
NO
58
M.D.-MEDICINE
6.
KIRAN SHARADCHANDRA KARNIK (MR.)
NONEXECUTIVE DIRECTOR
YES
NO
62
7.
SANJAY SHRENIK LALBHAI (MR.)
YES
NO
55
8.
PRASANNA CHANDRA SITAB CHANDRA SHRIMAL (DR.)
NONEXECUTIVE DIRECTOR NONEXECUTIVE DIRECTOR
B.SC.-PHYSICS/ 24/01/2001 P.G.DIPLOMAMANAGEMENT,IIM AHMEDABAD B.SC./ M.M.S. ENTREPRENEUR 23/01/2003
YES
NO
63
2.
Rs. in Crores
M.B.A./ PH.D.FINANCE
EXECUTIVE CHAIRMAN MANAGING DIRECTOR
23/06/1982
MANAGING DIRECTOR, TORRENT POWER GENERATION LTD. PARTNER, AMARCHAND & MANGALDAS & SURESH A.SHROFF & CO. WHOLETIME DIRECTORRESEARCH & DEVELOPMENT PRESIDENT, NASSCOM
19/10/2000
CONSULTANT & ACADEMICIAN
25/05/2001
20/08/1986
25/05/2001
27/06/2000
2007-08
2006-07
Sales & Operating Income
995.90
882.90
Operating Profits (PBDIT)
216.98
167.49
Less Depreciation
32.74
30.24
Less Net Interest Expense
18.40
13.15
165.84
124.10
Profit Before Tax & Exceptional Items Less Net Income Tax Expense Net Profit for the Period Balance brought forward from Last Year
10.32
11.14
155.52
112.96
62.02
48.39
217.53
161.35
Transfer to General Reserve
99.00
70.39
Proposed Equity Dividend
29.61
--
--
25.38
Distributable Profits Appropriated as under:
Interim Dividend Tax on Distributed Profits
5.03
3.56
Balance Carried Forward
83.89
62.02
Earnings Per Share
18.38
13.35
FINANCIAL RESULTS The summary of consolidated (Company and its subsidiaries) and standalone (Company) operating results for the year and appropriation of divisible profits is given below : (Rs. in Crores except per share data) Consolidated Standalone 2008-09 2007-08 2008-09 2007-08 Sales & Operating Income 1631 1355 1185 996 Operating Profits (PBDIT) 262 208 257 217 Less Depreciation 42 39 37 33 Less Net Interest Expense 19 20 20 18 Profit Before Exceptional Items & Tax 201 149 200 166 Less Exceptional Items 9 - - 9 - Less Tax Expense 7 14 4 10 Net Profit for the Year 185 135 187 156 Balance brought forward 3 2 84 62 Distributable Profits 188 137 271 218 Appropriated as under: Transfer to General Reserve 145 99 145 99 Proposed Equity Dividend 34 30 34 30 Tax on Distributed Profits 6 5 6 5 Balance Carried Forward 3 3 86 84 Earnings Per Share (Rs. per share) 21.79 15.92 22.07 18.38
Therapeutic Segment Company's Growth Segment Growth Cardiovascular 7.1% 13.2% Gastrointestinal 2.0% 8.2% CNS 9.5% 10.4% Anti-infective 4.2% 9.8% Pain management 1.2% 9.0% Anti-diabetics 20.1% 16.2% Source: ORG-IMS March 2009 MAT
Related Documents
Dr S S Bhoga
July 2020 10
Bhatt Cogent
June 2020 3
Sudhir Mandwa
May 2020 0
Prasanna Updated
August 2019 6